Emergency contraception (EC) is available in Ireland: EC is included in Ireland’s drug reimbursement policies and is available for purchase from pharmacies, hospitals, and family planning clinics, although EC is not included in national policies for family planning.
- Sexual & reproductive health background information
- Accessibility & prescription status
- Guidelines & common practices
- EC use
Sexual & reproductive health background information
|Female population aged 15-49||Mean age at first sexual intercourse||Mean age at birth of first child||Total fertility rate||% use of modern contraceptive methods|
Accessibility & prescription status
In Ireland, LNG EC is available behind the counter from pharmacies, hospitals, family planning clinics, and general practitioners, which means that EC is available without a prescription but is not on the shelves and needs to be requested in order to purchase. LNG EC is also available by prescription. Since May 2015 UPA EC is available without prescription (behind the counter) from pharmacies and in family planning clinics.
Both physicians and pharmacists are authorized to prescribe or provide LN EC
|Type of EC||Approximate Cost||Brand(s) Available|
|LNG||€ 40,47 (€ 6.01 if reimbursed)||NorLevo, Levonelle 1500|
|UPA||€ 57,82 (€ 19,60 if reimbursed)||ellaOne|
The cost of LNG EC is fully reimbursed when it is sold with a prescription to medical card holders, and it is delivered free of charge to low-income populations as well as to rape victims. The cost of UPA EC is reimbursed to the patient only if that patient is four or five days post coitus, and it is also delivered free of charge to low-income populations.
Guidelines & common practices
Although there are no guidelines devoted to EC, most practitioners in Ireland use the ones published by the UK Faculty of Sexual and Reproductive Healthcare.
Health care providers sometimes provide general information about EC during regular consultations but rarely prescribe EC in advance of need. Health care providers do not require a pregnancy test or a pelvic exam before prescribing EC.
|Ever use of EC||EC use in the last 12 months||% with no prescription||Repeated use of EC in last 12 months|
1 United Nations Department of Economic and Social Affairs, Population Division. World Population Prospects: The 2010 Revision. New York, 2011.
2 Durex Global Sex Survey Results 2005. Retrieved 20 June 2013, from http://www.durex.com/en-jp/sexualwellbeingsurvey/documents/gss2005result.pdf.
3 United Nations Economic Commission for Europe Statistical Division Database. Mean Age of Women at Birth of First Child by Country and Year. Updated 23 November 2012. Retrieved 19 June 2013, from http://w3.unece.org/pxweb/dialog/varval.asp?ma=04_GEFHAge1stChild_r&path=../database/STAT/30-GE/02-Families_households/&lang=1&ti=Mean+age+of+women+at+birth+of+first+child.
4 European health for all database (HFA-DB), World Health Organization Regional Office for Europe. Total fertility rate. Retrieved 18 June 2013, from http://data.euro.who.int/hfadb/.
5 United Nations Department of Economic and Social Affairs, Population Division. World Contraceptive Use 2012. New York, 2012.
Last update: December 2017